Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Associations between Long-Term Ambient PM 2.5 Exposure and Prevalence of Chronic Kidney Disease in China: A National Cross-Sectional Study
20 Pages Posted: 19 Feb 2020More...
Background: Chronic kidney disease (CKD) is one of the important global public health challenges. However, evidence regarding the associations between PM2.5 exposure over a broad range and CKD prevalence in the general population is extremely limited. Our aim is to explore the associations between long-term exposure to ambient PM2.5 and prevalence of CKD based on the China National Survey of CKD.
Methods: A cross-sectional survey of a nationally representative sample of 47 204 Chinese adults recruited at 13 provinces from different provinces was conducted from September 2009 to September 2010. Annual exposure to PM2.5 prior to the survey date was estimated at each participant’s address using validated satellite-based spatiotemporal model with a 10km×10km resolution. Participants with estimated glomerular filtration rate (eGFR) <60 mL/min/1・73 m 2 or with albuminuria were defined as CKD. Generalized additive mixed effects models were used to estimate the associations, and the influences of the potential modifiers were also analyzed.
Findings: Two-year mean PM2.5 concentration was 57・4 μg/m3, with a range from 31・3 to 87・5 μg/m3. A 10 μg/m3 increase in PM2.5 was positively associated with the prevalence of CKD with an odds ratio (OR) of 1・33 (95% confidence interval [CI]: 1・25, 1・41) and albuminuria with an OR of 1・47 (95% CI: 1・38-1・58). Stratified analyses indicated the associations were stronger in participants <65 years (vs. participants ≥65 years), in participants with normal weight (vs. overweight participants), and in participants without comorbid diseases (vs. those with comorbid diseases including diabetes, hypertension, and cardiovascular disease).
Interpretation: This study showed a significant association between long-term PM2.5 exposure over a broad range and increased prevalence of CKD in the national representative general population. The findings will provide important evidence for policy markers and public health practices to reduce the disease burden of CKD related to ambient PM2.5 pollution.
Funding Statement: This study was supported by grants from the National Natural Science Foundation of China (91846101, 81771938, 81301296, 81502780), Beijing Nova Programme Interdisciplinary Cooperation Project (Z191100001119008), the National Key R&D Program of the Ministry of Science and Technology of China (2016YFC1305400, 2017YFC0211601), the University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research (BMU20160466, BMU2018JI012, BMU2019JI005), and from Peking University (BMU2018MX020, PKU2017LCX05, PKU2019LCXQ008).
Declaration of Interests: The authors declare no competing interests.
Ethics Approval Statement: The ethics committee of Peking University First Hospital approved the study. All the participants gave written informed consent before data collection.
Keywords: ambient PM2.5; long-term exposure; chronic kidney disease
Suggested Citation: Suggested Citation